SEASIDE HEALTH SYSTEM
1. Target Overview & Investment Thesis
SEASIDE HEALTH SYSTEM is a 64-bed community hospital in nan, LA with $13.0M in net patient revenue and a 3.4% operating margin. The hospital serves a payer mix of 7.1% Medicare, 0.0% Medicaid, and 92.9% commercial.
Thesis: Turnaround. Our ML models identify $959K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.4% to 10.8% (+738bps).
| Net Revenue HCRIS | $13.0M |
| Current EBITDA COMPUTED | $445K |
| Operating Margin COMPUTED | 3.4% |
| Occupancy HCRIS | 48.8% |
| Revenue / Bed COMPUTED | $203K |
| Net-to-Gross HCRIS | 32.4% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of 3.4% places it above the state median. Among 76 size-comparable peers (32-128 beds), the median margin is -3.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (32-128), prioritizing same-state peers. 76 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SEASIDE HEALTH SYSTEM (Target) | LA | 64 | $13.0M | 3.4% |
| OCHSNER MEDICAL CENTER - KENNE | LA | 115 | $193.8M | -2.9% |
| ST. PATRICK HOSPITAL | LA | 100 | $189.4M | -7.4% |
| UNIVERSITY HOSPITAL & CLINICS | LA | 52 | $158.9M | -33.4% |
| SOUTHERN REGIONAL MEDICAL CORP | LA | 64 | $97.3M | -50.0% |
| OLH-SHREVEPORT-ST. MARY MEDICA | LA | 118 | $91.1M | -50.0% |
| OCHSNER LSU HEALTH MONROE | LA | 84 | $85.1M | -50.0% |
| NATCHITOCHES REGIONAL MEDICAL | LA | 81 | $82.4M | -21.8% |
| LAKE AREA MEDICAL CENTER | LA | 88 | $81.6M | 2.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $959K (738bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $273K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $260K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $258K | +199bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $158K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +7bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $445K |
| + RCM Uplift | +$959K |
| Pro Forma EBITDA | $1.4M |
| Current Margin | 3.4% |
| Pro Forma Margin | 10.8% |
| WC Released (1x) | $498K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $684K | $12.5M | 18.30x | 78.8% |
| Base (11x exit) | 10.0x | 11.0x | $684K | $14.0M | 20.45x | 82.9% |
| Bull Case | 9.0x | 11.0x | $616K | $17.4M | 28.23x | 95.0% |
| Bull (12x exit) | 9.0x | 12.0x | $616K | $19.1M | 31.09x | 98.8% |
| Bear Case | 11.0x | 10.0x | $753K | $7.5M | 9.97x | 58.4% |
| Bear (11x exit) | 11.0x | 11.0x | $753K | $8.5M | 11.29x | 62.4% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 76 hospitals with 32-128 beds
- Same-state prioritization (n=77)
- Comp margins: P25=-22.6% / P50=-3.3% / P75=4.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.